4'-(3-Azabicyclo[4.1.0]heptan-6-yl)-5-(4-(4-(trifluoromethyl)-phenyl)-1H-1,2,3-triazol-1-yl)-[1,1'-biphenyl]-3-carboxylic Acid

ID: ALA4637158

Chembl Id: CHEMBL4637158

PubChem CID: 139392339

Max Phase: Preclinical

Molecular Formula: C28H23F3N4O2

Molecular Weight: 504.51

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O)c1cc(-c2ccc(C34CCNCC3C4)cc2)cc(-n2cc(-c3ccc(C(F)(F)F)cc3)nn2)c1

Standard InChI:  InChI=1S/C28H23F3N4O2/c29-28(30,31)22-7-3-18(4-8-22)25-16-35(34-33-25)24-12-19(11-20(13-24)26(36)37)17-1-5-21(6-2-17)27-9-10-32-15-23(27)14-27/h1-8,11-13,16,23,32H,9-10,14-15H2,(H,36,37)

Standard InChI Key:  DPNFGEIZRQGOMX-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4637158

    ---

Associated Targets(Human)

OPRD1 Tclin Delta opioid receptor (15096 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
P2RY14 Tchem Purinergic receptor P2Y14 (692 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

P2ry14 P2Y purinoceptor 14 (107 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 504.51Molecular Weight (Monoisotopic): 504.1773AlogP: 5.57#Rotatable Bonds: 5
Polar Surface Area: 80.04Molecular Species: ZWITTERIONHBA: 5HBD: 2
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 3.85CX Basic pKa: 10.07CX LogP: 3.28CX LogD: 3.28
Aromatic Rings: 4Heavy Atoms: 37QED Weighted: 0.37Np Likeness Score: -0.68

References

1. Jung YH, Yu J, Wen Z, Salmaso V, Karcz TP, Phung NB, Chen Z, Duca S, Bennett JM, Dudas S, Salvemini D, Gao ZG, Cook DN, Jacobson KA..  (2020)  Exploration of Alternative Scaffolds for P2Y14 Receptor Antagonists Containing a Biaryl Core.,  63  (17): [PMID:32787142] [10.1021/acs.jmedchem.0c00745]

Source